Back

Trends in utilization and clinical outcomes of sodium-glucose co-transporter 2 inhibitors in patients with heart failure undergoing mitral transcatheter edge-to-edge repair

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Heart failure prevention: pharmacist-led guideline-directed medical therapy and training Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Arman Qamar

NorthShore University Health System, Chicago (United States of America)

6 More presentations in this session

Presentation thumbnail
Oral ferric maltol in heart failure patients with iron deficiency anaemia according to NYHA functional class
Doctor W. Geller (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Association of an early multidisciplinary HF pathway and inpatient rehabilitation with 1-year survival: a four-group real-world analysis (2020–2025)
Doctor R. Fujimoto (Tsuyama, JP)
Abstract Slides Video
Presentation thumbnail
Inpatient-initiated and home-based exercise training reduces heart failure hospitalization and reverses frailty: a prospective randomized study
Doctor K. Kim (Incheon, KR)
Abstract Slides
Presentation thumbnail
START-HF: a multi-centre evaluation of centralised pharmacist-led remote GDMT optimisation in HFrEF
Doctor A. Kirupananthavel (London, GB)
Abstract Slides Video
Presentation thumbnail
Evaluation of primary prevention ICD efficacy in late elderly heart failure patients: a multicenter study
Doctor A. Brin (Jerusalem, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure prevention: pharmacist-led guideline-directed medical therapy and training

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes
31 August 2025
thumbnail
Congress Presentation
Outcomes of sacubitril/valsartan plus SGLT2 inhibitors versus SGLT2 inhibitors in heart failure with reduced ejection fraction: a propensity-matched real-world analysis
28 August 2026
thumbnail
Congress Presentation
Timing matters: clinical outcomes of early sodium-glucose cotransporter-2 inhibitor initiation in acute heart failure
10 May 2026
thumbnail
Congress Presentation
Description of the profile of the patient with heart failure depending on the discharge service and the possible optimization of treatment with SGLT2i in a retrospective cohort from 2021 to 2022
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources